# Atropine or Ephedrine Pretreatment for Preventing Bradycardia in Elderly Patients

Study · id `cardio:ct-nct03984526` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03984526](<https://clinicaltrials.gov/study/NCT03984526>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT03984526

Browse, organ or system: Heart  
Browse, condition area: Heart rhythm problems  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 102 participants.

## Technical summary

Registry record NCT03984526. Randomized; double masking; primary purpose prevention. Start 2019-06-25 (actual); primary completion 2020-09-15 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; double masking; primary purpose prevention
- Phase: Phase 4
- Enrolled: 102 participants (enrolled count; ClinicalTrials.gov record NCT03984526, source copy `cardio:ctgov-nct03984526-2021-02-04`, retrieved 2026-10-26)
- Started: 2019-06-25 (actual) (ClinicalTrials.gov record NCT03984526, source copy `cardio:ctgov-nct03984526-2021-02-04`, retrieved 2026-10-26)
- Primary completion: 2020-09-15 (actual) (ClinicalTrials.gov record NCT03984526, source copy `cardio:ctgov-nct03984526-2021-02-04`, retrieved 2026-10-26)
- Completion: 2020-09-15 (actual) (ClinicalTrials.gov record NCT03984526, source copy `cardio:ctgov-nct03984526-2021-02-04`, retrieved 2026-10-26)
- Countries: South Korea (ClinicalTrials.gov record NCT03984526, source copy `cardio:ctgov-nct03984526-2021-02-04`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03984526-2021-02-04`, retrieved 2026-10-26)

## The registry's words

- Brief title: Atropine or Ephedrine Pretreatment for Preventing Bradycardia in Elderly Patients
- Condition: Anesthesia, Spinal
- Condition: Dexmedetomidine
- Condition: Bradycardia
- Intervention (Drug): normal saline
- Intervention (Drug): atropine 0.5mg
- Intervention (Drug): ephedrine 8mg
- Lead sponsor: Ajou University School of Medicine
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Bradycardia (`cardio:bradycardia`)
- Registry lists this organization as the lead sponsor: Ajou University School of Medicine (`cardio:org-ajou-university-school-of-medicine`)

## Provenance

Content hash: 3a07f03797bc270aeeeaf43d7770b926ce765afd3fb77117448cb2e6ee4d8496
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
